To confirm market demand in the US and international territories, management has traveled extensively to demonstrate prototypes with surgeons, hospital executives and distribution partners. Results were greater than 99% positive, with surgeons and health care executives not only seeking to adopt the devices, but also to participate in their launch (whether as a medical advisor, to provide regional training facilities, to become a seller/distributor or an investor).
To support an efficient and robust launch of multiple LuminusMicro products, all departments are fully supported by top medical device executives, specialized firms in medical law, in patents and regulatory compliance, top distributors and educational facilities, and the largest US manufacturers to handle the expected volume created by the one-use, sterile packaging of LuminusMicro devices.
We plan to brand and release our microsurgical devices into eleven high-demand markets:
Ear Nose & Throat (ENTnano)
Orthopedics (Luminus Ortho)
Neuro-Spine (Luminus Neuro)
Women’s Health (Luminus GYN)
Genito-Urinary (Luminus Urinary)
Pulmonary/Thoracic (Luminus Pulmonary)
Cardio & Vascular (Luminus Vascular)
Gastrointestinal (Luminus GI)
Dental (DDS Corp Dental Device Solutions)
Targeted Cancer and Regenerative (Nano Delivery Systems)
Healthcare Data Mining / Al (Med Reference, Inc)
Leveraging our foundation of manufacturing, compliance, and market demand for the entire portfolio of markets above, LuminusMicro is ready to deploy the first embodiment of our core technology – ENTnano. ENTnano will deliver a powerful new set of capabilities to the Ear, Nose and Throat market, where demand is peaking for the exact solutions that LuminusMicro provides.
